This report is organized into six chapters. The first chapter provides an introduction and presents a brief situation analysis of current research and development and manufacturing capacities in the region...
Each method has advantages and drawbacks, requires different levels of management capacity; methods are often combined to get better results and address tradeoffs; and costing methodology and required...
This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of...
Romania has a pharmaceutical market of 5.47 billion lei (1,550 million Euro) in 2006, where the market for prescription drugs was about 4.58 billion lei, of which 80 percent are financed by health insurance...
Sustainable access to affordable, high-quality medicines is an important component in all health care systems but remains limited in many African countries. Supply and distribution of medicines are a fundamental...
This book discusses the wide range of challenges faced by policy makers in the pharmaceutical sector, presents the current know-how in terms of policy measures, and provides specific examples of policy...
Pharmaceuticals are a critical input for the health sector. At the same time, the drug business sustains many individual and corporate livelihoods and produces handsome returns for those involved in the...
Sustainable access to affordable, quality medicines is an important component of health care but in many African countries it continues to be limited. Commonly reported problems include poor supply chain...
There is a strong political will in the Western Balkan states to align the region's pharmaceutical legislation and practice with that of the European Union. Accordingly, recent policy changes were aimed...
Pharmaceuticals are essential to achieve health outcomes, but are at the same time a major cost factor in every health system. From a patient perspective, access to pharmaceuticals is a proxy for the functioning...
About the World Bank Group and Staff Exchange Program (SEP). Partnership programs at a glance. A word of Thanks, by Benedicte Boullet. Moving in, moving on. A first Voice Secondment Program (VSP) cohort...
In virtually every country in the world, governments, social security fund managers and health insurers are struggling with ever increasing drug bills. This note explains cost drivers, provides insights...
Many health projects rely on a regular supply of quality pharmaceuticals. Here is a practical guide how to assure drug quality along the distribution chain and win the fight against substandard and counterfeit...
Regulation of pharmaceuticals is a complex task. Andreas Seiter's note reviews the role of drug regulatory authorities in developing countries and discusses how to set priorities in line with the overall...
Counterfeit and substandard drugs jeopardize health and waste money. Andreas Seiter reviews dimensions of the problem and contributing factors, and how countries can ensure drug quality. Pharmaceutical...
What factors must be weighed when deciding whether to promote local manufacturing of pharmaceuticals in developing countries? Andreas Seiter's note summarizes pros, cons and key issues. Pharmaceuticals...
في هذا الإصدار: مقال رئيسي: إلى شعب لبنان؛ آفاق لإصلاح قطاع الأدوية والمستحضرات الصيدلانية في لبنان؛ التطورات الاقتصادية الأخيرة؛ عمليات مجموعة البنك الدولي؛ مسابقة سوق التنمية في لبنان- مسابقة عام 2005؛...
This newsletter is a quarterly publication of the Lebanon Country Office. This issue features: Editorial: To the People of Lebanon; Perspectives for Pharmaceutical Reform in Lebanon; Recent Economic Developments;...